|
1
|
Younes A: Novel treatment strategies for
patients with relapsed classical Hodgkin lymphoma. Hematology.
2009:507–519. 2009. View Article : Google Scholar
|
|
2
|
Eichenauer DA, Böll B and Diehl V:
Pharmacotherapy of Hodgkin lymphoma: standard approaches and future
perspectives. Expert Opin Pharmacother. 15:1139–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tefferi A: Pathogenesis of myelofibrosis
with myeloid metaplasia. J Clin Oncol. 23:8520–8530. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tefferi A: Primary myelofibrosis: 2014
update on diagnosis, risk-stratification, and management. Am J
Hematol. 89:915–925. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Niino D, Tsuchiya T, Tomonaga M, Miyazaki
Y and Ohshima K: Clinicopathological features of acute
megakaryoblastic leukaemia: Relationship between fibrosis and
platelet-derived growth factor. Pathol Int. 63:141–149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aljinovic N, Bogusz AM, Kantarci S, Buck
TP and Dewar R: An unusual case of Philadelphia chromosome-positive
chronic myelogenous leukemia with trisomy 19 presenting with
megakaryoblastosis and myelofibrosis. Arch Pathol Lab Med.
137:1147–1151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Araki H, Matsunaga T, Murase K, Kuroda H,
Kuribayashi K, Terui T and Niitsu Y: Successful induction and
complete improvement of myelofibrosis and erythema nosodum with
cladribine in a case of hairy cell leukemia. Gan To Kagaku Ryoho.
31:965–969. 2004.(In Japanese). PubMed/NCBI
|
|
8
|
Okabe S, Miyazawa K, Lguchi T, Sumi M,
Takaku T, Ito Y, Kimura Y, Serizawa H, Mukai K and Ohyashiki K:
Peripheral T-cell lymphoma together with myelofibrosis with
elevated plasma transforming growth factor-β1. Leuk Lymphoma.
46:599–602. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kikukawa M, Umahara T, Kikawada M, Kanaya
K, Sakurai H, Shin K, Mori M and Iwamoto T: Peripheral T-cell
lymphoma presenting as myelofibrosis with the expression of basic
fibroblast growth factor. Geriatr Gerontol Int. 9:395–398. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsui K, Adachi M, Tominaga T, Shinohara
S and Kamei T: Angioimmunoblastic T cell lymphoma associated with
reversible myelofibrosis. Int Med. 47:1921–1924. 2008. View Article : Google Scholar
|
|
11
|
Rao SA, Gottesman SR, Nguyen MC and
Braverman AS: T cell lymphoma associated with myelofibrosis. Leuk
Lymphoma. 44:715–718. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abe Y, Ohshima K, Shiratsuchi M, Honda K,
Nishimura J, Nawata H and Muta K: Cytotoxic T-cell lymphoma
presenting as secondary myelofibrosis with high levels of PDGF and
TGF-beta. Eur J Haematol. 66:210–212. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsunaga T, Takemoto N, Miyajima N, Okuda
T, Nagashima H, Sato T, Terui T, Sasaki H, Ohmi N, et al: Splenic
marginal zone lymphoma presenting as myelofibrosis associated with
bone marrow involvement of lymphoma cells which secrete a large
amount of TGF-beta. Ann Hematol. 83:322–325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meadows LM, Rosse WR, Moore JO, Crawford
J, Laszlo J and Kaufman RE: Hodgkin's disease presenting as
myelofibrosis. Cancer. 64:1720–1726. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carroll WL, Berberich FR and Glader BE:
Pancytopenia with myelofibrosis. An unusual presentation of
childhood Hodgkin's disease. Clin Pediatr (Phila). 25:106–108.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vukelja SJ, Krishnan J, Ward FT and
Redmond J III: Synchronous Hodgkin's disease and myelofibrosis
terminating with granulocytic sarcoma and acute megakaryocytic
leukemia. South Med J. 83:1317–1320. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Viola MV, Kovi J and Nukhopadhyay M:
Reversal of myelofibrosis in Hodgkin disease. JAMA. 223:1145–1146.
1973. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Izumi T and Ozawa K: Clinical staging
classification of non-Hodgkin's lymphoma. Nihon Rinsho. 58:598–601.
2000.(In Japanese). PubMed/NCBI
|
|
19
|
Viallard JF, Parrens M, Boiron JM, Texier
J, Mercie P and Pellegrin JL: Reversible myelofibrosis induced by
tuberculosis. Clin Infect Dis. 34:1641–1643. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Atasever T, Vural G, Yenidünya S, Ataoğlu
O, Atavci S and Unlü M: Tc-99m MIBI bone marrow uptake in bone
marrow fibrosis secondary to metastatic breast carcinoma. Clin Nucl
Med. 22:655–656. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gabali AM, Jazaerly T, Chang CC, Cleveland
R and Kass L: Simultaneous hepatosplenic T-cell lymphoma and
myelofibrosis. Avicenna J Med. 4:34–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gisselbrecht C, Gaulard P, Lepage E,
Coiffier B, Brière J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L,
Tilly H, et al: Prognostic significance of T-cell phenotype in
aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes
de l'Adulte (GELA). Blood. 92:76–82. 1998.PubMed/NCBI
|
|
23
|
Tefferi A: Myelofibrosis with myeloid
metaplasia. N Engl J Med. 342:1255–1265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Charni Chaabane S, Coomans de Brachène A,
Essaghir A, Velghe A, Lo Re S, Stockis J, Lucas S, Khachigian LM,
Huaux F and Demoulin JB: PDGF-D expression is down-regulated by
TGFβ in fibroblasts. PLoS One. 9:e1086562014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang JC, Chang TH, Goldberg A, Novetsky
AD, Lichter S and Lipton J: Quantitative analysis of growth factor
production in the mechanism of fibrosis in agnogenic myeloid
metaplasia. Exp Hematol. 34:1617–1623. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kadin ME, Agnarsson BA, Ellingsworth LR
and Newcom SR: Immunohistochemical evidence of a role for
transforming growth factor beta in the pathogenesis of nodular
sclerosing Hodgkin's disease. Am J Pathol. 136:1209–1214.
1990.PubMed/NCBI
|
|
27
|
Newcom SR and Tagra KK: High molecular
weight transforming growth factor beta is excreted in the urine in
active nodular sclerosing Hodgkin's disease. Cancer Res.
52:6768–6773. 1992.PubMed/NCBI
|
